AzurRx BioPharma, Inc. Banner Image

AzurRx BioPharma, Inc.

  • Ticker AZRX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
AzurRx BioPharma, Inc. Logo Image
  • 1-10 Employees
  • Based in Langlade, Wisconsin
AzurRx BioPharma, Inc. (NASDAQ: AZRX) is a biopharmaceutical company specializing in the research and development of non-systemic biologics for gastrointestinal disorders. The Company is focused on the development of its lead drug candidate, MS1819. AzurRx is currently conducting two Phase 2 clinical trials of MS1819: the OPTION 2 monotherapy trial and the Combination therapy trial, consistingMore of MS1819 in conjunction with porcine-derived pancreatic enzyme replacement therapy, the current standard of care. The Company is headquartered in New York, New York, with clinical operations in Hayward, California.
4.8 / 5.0 (122)

AzurRx BioPharma, Inc. reports have an aggregate usefulness score of 4.8 based on 122 reviews.

AzurRx BioPharma, Inc.

Most Recent Annual Report

AzurRx BioPharma, Inc.
MOST RECENT 2020 Form 10K
AzurRx BioPharma, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!